News
-
-
-
-
REGULATED PRESS RELEASE
Cie du Bois Sauvage: Buy back of own shares – week from 15/04/2024 to 19/04/2024
Cie du Bois Sauvage announces buy-back of own shares in compliance with authorization from the extraordinary general meeting on 28/04/2021. Details of shares purchased from 15/04/2024 to 19/04/2024 disclosed -
-
-
-
-
PRESS RELEASE
Screening completed: Berlin Cures achieves key milestone in BC 007 Phase II Trial for treatment of Long COVID
Berlin Cures achieves key milestone in BC 007 Phase II trial for Long COVID treatment by successfully completing patient screening, marking a significant step in developing an effective therapy -